Investor Conference Call

FY/Q4 2019 Results

Thursday, February 27, 2020
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)


Investor News February 27, 2020

Fiscal 2019:

Bayer strategically and operationally successful

Group sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros / EBITDA before special items increases by 28.3 percent to 11.503 billion euros / Core earnings per share up by 14.3 percent to 6.40 euros / Net income rises 141.4 percent to 4.091 billion euros - gain of 1.637 billion euros on sale of Currenta stake / Free cash flow of 4.214 billion euros above expectations / Proposed dividend of 2.80 euros per share / Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business / Pharmaceuticals shows encouraging business development / Sales growth at Consumer Health, earnings at prior-year level despite divestments / Ongoing portfolio, structural and efficiency measures implemented successfully / Glyphosate's positive safety profile confirmed - appeal and mediation proceedings moving forward / Outlook for 2020: increase in sales, earnings and free cash flow / Ambitious sustainability targets set MORE

?


baumann

Werner Baumann
CEO of
Bayer AG

Audio recording of the investor conference call (including slides)

?

Audio file

You can also play the audio recording on your mobile device.

?

Presentation charts

Q4 2019 Analyst and Investor Briefing

nickl

Wolfgang Nickl
CFO of
Bayer AG

2019 Annual Report

Transcript

FY/Q4 2019 All in One Package for Investors and Analysts